Andira is a biopharmaceutical firm that delivers cannabinoid therapeutics and consumer healthcare products globally.
Andira Pharmaceuticals has raised $393K in total funding. The most recent round was Seed. The last funding was announced in March 2022.
Andira Pharmaceuticals's investors include US Capital Global.
Andira Pharmaceuticals is headquartered in Vancouver, Canada.
Andira is a biopharmaceutical firm that delivers cannabinoid therapeutics and consumer healthcare products globally.
Andira Pharmaceuticals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Andira Pharmaceuticals — Funding & Investors." VCBacked, March 14, 2022, https://www.vcbacked.co/company/andira-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2022). Andira Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/andira-pharmaceuticals
{{cite web |title=Andira Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/andira-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated